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Summary: Nestin-Cre mice are widely used to generate gene deletions in the developing brain. Surprisingly, few Nestin-Cre lines have been characterized for their temporal and brain region-specific recombination. In addition, some Nestin-Cre lines express Cre outside the central nervous system, making it difficult to choose appropriate lines for targeting genes with brain regionrestricted expression. Here we describe the properties of a Nestin-Cre transgenic line and its use for conditional deletions of Pitx2, a paired-like homeodomain transcription factor. We report that Nestin-Cre conditional Pitx2 mutant mice have ocular and craniofacial defects consistent with the role of human PITX2 in Rieger syndrome. Conditional mutants exhibit defects in midbrain neuronal development similar to those in Pitx2 homozygous null embryos, but lack the abnormalities in subthalamic nucleus neurons that occur with complete loss of Pitx2 function. These data indicate that normal differentiation of midbrain neurons depends upon adequate Pitx2 function during the period of active neurogenesis. genesis 44:336-344, 2006 44:336-344, . Published 2006 Wiley-Liss, Inc. y Key words: neuronal development; transcription; conditional knock-out Transcriptional regulation of neuronal development is critical for generating diversity and regional specificity in the brain. Gene targeting with Cre=loxP approaches makes it possible to study precise roles of transcription factors in discrete populations of developing neurons. Nestin is expressed in brain neural progenitors as early as e8.5, is down-regulated at the end of neurogenesis, and is transiently expressed in presomitic mesoderm and somites (Dahlstrand et al., 1995; Lendahl et al., 1990) . Enhancer elements in the rat nestin second intron drive reporter gene expression in the neuroepithelium by e10.5 (Zimmerman et al., 1994) , and have been used to generate several different lines of NestinCre mice (Isaka et al., 1999; Petersen et al., 2002; Tronche et al., 1999; Trumpp et al., 1999) .
The Nestin-Cre mice for our study have been used successfully to achieve gene deletions in the central nervous system during development (Bates et al., 1999; Fan et al., 2001; Groszer et al., 2001) . This Nestin-Cre line is not brain specific; it also expresses Cre in branchial archderived tissues and the germline, and exhibits preferential expression from the male allele . Despite the availability and use of these mice for over six years, Cre expression sites in the brain and other tissues are not well characterized. Instead, prior studies relied on PCR or Southern based analysis of whole brain tissues to test for Nestin-Cre mediated recombination (Bates et al., 1999; Fan et al., 2001; Groszer et al., 2001) .
To characterize Nestin-Cre activity during brain development, we mated male Nestin-Cre transgenic (Tg) mice with homozygous Rosa26 reporter (R26R) females and processed embryos (e10.5-e14.5) for X-gal staining (N ¼ at least 3 for each time point). At e10.5, Cre recombination is high in the dorsal and ventral midbrain, dorsal and ventral hindbrain, ventral spinal cord, and branchial arches, and absent in future thalamus, hypothalamus, telencephalon, or mammillary recess (the area containing progenitors of subthalamic nucleus neurons) (see Fig. 1 ). By e12.5, b-galactosidase activity is extensive throughout the midbrain and hindbrain, and also present in the developing hypothalamus, thalamus, subthalamic nucleus region, and telencephalon (see Fig. 2 ). At e14.5, b-galactosidase activity is present throughout the brain and the spinal cord, with mosaic expression in the pituitary, palate, tongue, facial mesenchyme, maxillary and mandibular processes, kidney, and adrenal gland ( Fig. 2 and Supplementary Fig. S1 ). Many tissues exhibit mosaicism of b-galactosidase, suggesting not all cells have undergone Cre-mediated recombination.
There is a delay between Cre expression and b-galactosidase activity, and differences in mouse reporter strains can affect interpretation of Cre activity patterns (Branda and Dymecki, 2004) . Thus, some early Creexpressing cells may not have been identified in our studies. However, this seems unlikely since two other Cre reporter strains (Z=AP and Z=EG mice) yielded similar e9.5-e10.5 Cre activity patterns in the midbrain when mated with the same line of Nestin-Cre mice (unpublished observations, A. Trumpp). In addition, the initial report characterizing R26R mice demonstrated ubiquitous expression of the lacZ reporter in mouse embryos from as early as implantation (Soriano, 1999) .
E10.5-15.5 is a period of intense neurogenesis throughout the developing mouse brain (Easter et al., 1993) ; thus, we hypothesized that Nestin-Cre mediated recombination during this period could be valuable for studying late effects of Pitx2 deficiency in neuronal development. Pitx2 is a member of the paired-like family of homeodomain transcription factors essential for normal development in humans and mice (Gage et al., 1999b; Kitamura et al., 1999; Lin et al., 1999; Liu et al., 2001;  FIG. 1. Nestin-Cre mediated recombination in the e10.5 mouse embryo. Nestin-Cre, R26R=+ embryos stained at e10.5 with X-gal to detect b-galactosidase activity and counterstained with eosin. Lines over the sagittal section in (a) show the plane of frontal sections in (b-h). Lines over the frontal section in (i) show planes of sagittal sections in (j-m). Boxes in (d), (e), (f), (h), and (k) are enlarged and shown in (n), (o), (p), (q), and (r), respectively. b-Galactosidase activity (X-gal stain) is prominent in the dorsal and ventral midbrain (dmb and vmb), ventral spinal cord (sc), branchial arches (BA), and dorsal and ventral hindbrain (dhb and vhb). There is no b-galactosidase activity in the e10.5 mammillary recess (MR) (which contains subthalamic nucleus neuronal progenitors) or in the telencephalon (tel).
FIG. 2.
Nestin-Cre mediated recombination in the e12.5-14.5 mouse embryo. Sagittal sections from X-gal stained e12.5 (a, b) or e14.5 (c, d) Nestin-Cre, R26R=+ embryos. In addition to the areas of recombination at e10.5, X-gal is present at e12.5 in the telencephalon (tel), thalamus (thal), and hypothalamus (hypo). At e14.5, X-gal stain is present throughout the region containing the subthalamic nucleus (STN) and in scattered cells of the facial mesenchyme (fm), pituitary (pit), palate (pal), inner ear (ie), kidney (kid), and adrenal gland (adr). Other abbreviations -tng, tongue; sc, spinal cord; vhb, ventral hindbrain; mb, midbrain. Semina et al., 1997) . In humans, autosomal dominant haploinsufficient PITX2 mutations cause Rieger syndrome, characterized by eye abnormalities, umbilical defects, hypodontia, craniofacial abnormalities, and occasional central nervous system defects (Idrees et al., 2006; Semina et al., 1997) .
In mice, Pitx2 is expressed in the developing heart, eye, pituitary, teeth, tongue, maxillary and mandibular epithelia, and in discrete regions of the developing central nervous system, including the mammillary region, subthalamic nucleus, superior colliculus, hindbrain, and zona limitans intrathalamica (Gage et al., 1999a; Kitamura et al., 1997; Martin et al., 2002; Mucchielli et al., 1996) . Mice with complete loss of Pitx2 function (Pitx2 À=À ) die by e15 with severe defects in heart, craniofacial structures, teeth, eyes, and pituitary gland (Gage et al., 1999b; Kitamura et al., 1999; Lin et al., 1999; Liu et al., 2001) . In the pituitary, Pitx2 is required at several different stages of development, with roles in early progenitor cell formation and later lineage specification (Charles et al., 2005; Suh et al., 2002) . Our prior work showed that gene expression in Pitx2 homozygous null embryos is disrupted in the subthalamic nucleus and mislocalized in the midbrain, suggesting delayed or arrested neuronal migration or differentiation (Martin et al., 2004) .
To generate Pitx2NCre mutants (see Fig. 3 ), we mated male Nestin-Cre Tg, Pitx2 þ=À mice with Pitx2 flox=flox females, since the Nestin-Cre transgene is preferentially expressed from the paternal allele . Offspring from this mating are homozygous Pitx2 null in Nestin-Cre lineage cells, and heterozygous Pitx2 null elsewhere. Conditional Pitx2 flox=flox mice contain loxP sites flanking the Pitx2 homeodomain-containing exon 5 and exhibit no phenotypic abnormalities (Evans and Gage, 2005; Gage et al., 1999b) . To examine postnatal survival of Pitx2NCre mutants, pups were checked daily, tail DNA isolated at postnatal days 1-7, and DNA genotyped for Nestin-Cre and Pitx2 wild-type, null, and floxed alleles, as previously described (Gage et al., 1999b; Trumpp et al., 1999) . Pups of genotype NestinCre Tg, Pitx2
À=flox (Pitx2NCre mutants; N ¼ 5) survived to postnatal day 1, whereas all pups of the three other genotypes (Nestin-Cre Tg; Pitx2 þ=flox N ¼ 8; Non-Tg; Pitx2 þ=flox N ¼ 14; Non-Tg Pitx2 À=flox N ¼ 6) survived to postnatal day 7, the latest timepoint analyzed. Extended survival of Pitx2 conditional mutants beyond e15 enabled us to expand our analysis of the Pitx2 deficient brain to late embryonic periods.
Pitx2NCre mutant embryos exhibit kinked tails, a pointed snout, and a fused mouth (see Fig. 3 ), and similar ocular anomalies (medially displaced eyes) as in homozygous Pitx2 null embryos (Gage et al., 1999b) . Pitx2NCre embryos also have hypoplastic teeth and other craniofacial tissues (see Fig. 3 ), consistent with b-galactosidase activity in the developing branchial arches (see Fig. 1 ) and with prior reports of Nestin-Cre mediated Fgf8 deletion in branchial arch-derived tissues . The Pitx2NCre mutant craniofacial phenotype resembles that of human Rieger syndrome, providing evidence for conversion of the Pitx2 flox to Pitx2 null allele in craniofacial tissues; thus, Pitx2NCre embryos are also useful for understanding the morphogenesis of Pitx2-dependent craniofacial structures.
Since homozygous Pitx2 null embryos have defects in neuronal differentiation, we hypothesized that similar effects might also occur in Pitx2NCre mutants. To test this, we used a Pitx2 in situ probe that recognizes wildtype, Pitx2 flox , and recombined (Pitx2 null or Pitx2 -) alleles (Martin et al., 2002 (Martin et al., , 2004 to track wildtype, heterozygous, and homozygous mutant Pitx2-expressing neurons. We examined Pitx2NCre embryos at e14.5 (the latest surviving stage of homozygous Pitx2 null embryos) to compare subthalamic nucleus and midbrain phenotypes between complete and conditional null mutants. As in homozygous Pitx2 null embryos (Martin et al., 2004) , the midbrain of e14.5 Pitx2NCre mutants exhibits a shift in Pitx2 mRNA expression toward the midline (see Fig. 4 ). This effect persists in e18.5 embryos, in which Pitx2 mRNA is dispersed throughout the Pitx2NCre midbrain, in contrast to the tight layer of Pitx2 mRNA seen in control embryos (see Fig. 5 ). As in homozygous Pitx2 nulls, PITX2 immunofluorescence is undetectable in the e14.5 (and e18.5) midbrain of Pitx2NCre mutants (Figs. 4 and 5) , consistent with absence of PITX2 protein from a null (recombined) allele (Hjalt et al., 2000; Martin et al., 2004) . These data argue against a simple developmental delay or change in gene expression as the explanation for shifted locations of Pitx2 mutant midbrain neurons, and suggest an ongoing requirement (between e14.5 and e18.5) for Pitx2 in midbrain neuronal differentiation or survival.
The homozygous Pitx2 null e14.5 subthalamic nucleus region fails to express multiple neuronal markers, including Pitx2 mRNA, PITX2 immunofluorescence, and calretinin (Martin et al., 2004) . In contrast, both Pitx2 mRNA and PITX2 immunofluorescence are present in the subthalamic nucleus of e14.5 (see Fig. 4 ) and e18.5 (see Fig. 6 ) Pitx2NCre mutants, albeit at slightly reduced levels and in a disorganized pattern compared with control littermates. Unlike in homozygous Pitx2 nulls, in Pitx2NCre mutants there is no increase in Pitx2 mRNA around the third ventricle to suggest an accumulation of mutant cells (Martin et al., 2004) . The majority of subthalamic nucleus neurons are generated in the mouse between e10.5 and e14.5 (Martin et al., 2002 (Martin et al., , 2004 , raising the possibility that Pitx2NCre mutant neurons born between e10.5 and e12.5 (prior to the onset of Nestin-Cre Tg expression in the mammillary region ( Figs.  1 and 2) ) escape recombination at the Pitx2 locus. These genotypic Pitx2 flox=À neurons would still express PITX2 protein and could migrate through the neuroepithelium toward the subthalamic nucleus.
The slight reduction in size and disorganization of the subthalamic nucleus in Pitx2NCre mutants suggest that some neurons (i.e. those born at e12.5 or later) may undergo Cre-mediated recombination, lose Pitx2 function, and either fail to migrate to the nucleus, die, or adopt alternative fates. Additional studies using reporter tagged alleles are necessary to distinguish among these possibilities. There is detectable b-galactosidase activity in the subthalamic nucleus of e18.5 Nestin-Cre, R26R embryos (see Fig. 6) ; however, low level mosaicism for Cre-negative cells in the developing subthalamic nucleus might have been missed in our analysis. An intriguing possibility is that deletion of Pitx2 in dividing progenitors may have more severe effects on neuronal differentiation or migration than deletion of Pitx2 in postmitotic migratory subthalamic nucleus neurons, but this remains to be determined. Further experiments using neural spe- -=flox mice (Pitx2NCre mutants, (d-f)). Pitx2NCre mutants exhibit a small pointed snout, fused mouth, kinked tail, and slightly reduced size compared to control embryos. Pitx2NCre mutants (j-l) also have a hypoplastic tongue (t), teeth (th), and medially displaced eyes in comparison with controls (g-i).
cific Cre deleter strains with temporal control and earlier onset of expression will help determine whether Pitx2 has distinct roles in neurogenesis versus neuronal migration and differentiation, and whether these effects are unique to specific brain regions.
METHODS

Mice
All procedures involving the use of mice were approved by the University of Michigan Committee on the Use and Care of Animals (UCUCA). Nestin-Cre transgenic mice were obtained from Gail Martin and maintained on a C57BL=6J background. Rosa26 reporter mice (R26R), line B6.129S4-Gt(Rosa)26Sor tm1Sor =J (Soriano, 1999) , were obtained from The Jackson Laboratory (www.jax.org) and maintained in our mouse colony as homozygotes. Pitx2
À and Pitx2 flox alleles were as previously described (Gage et al., 1999b; Martin et al., 2004) , and were maintained on a C57BL=6J background to N7 generation. Pitx2 alleles were genotyped by PCR using previously described primers (Gage et al., 1999b) . (Pitx2 +=-, Nestin-Cre Tg) (a, c, e, g) and Pitx2NCre mutant (b, d, f, h) embryos at e14.5. Pitx2 mRNA (a, b, e, f), which detects wildtype, flox, and recombined (null) alleles, is shifted medially (b) and PITX2 immunofluorescence is absent in the midbrain of Pitx2NCre mutants (d) compared to controls (a, c). These results are similar to the midbrain phenotype of e14.5 homozygous Pitx2 null embryos (Martin et al., 2004) . Subthalamic nucleus Pitx2 mRNA (e, f; hatched ovals) and immunofluorescence (g, h) are slightly reduced in Pitx2NCre mutants, unlike homozygous e14.5 Pitx2 null embryos, which exhibit complete loss of Pitx2 mRNA and protein in the subthalamic nucleus (Martin et al., 2004) . Scale bars are 100 lm in (a-f) and 50 lm in (g) and (h).
The Nestin-Cre transgene was detected using forward primer 5 0 -CCGGGGTGTCTGGCTGTATCTCAA-3 0 and reverse primer 5 0 -CGGTGCTAACCAGCGTTTTC-3 0 (Invitrogen, Carlsbad, CA). For R26R mice, genotyping was done using primers that detect wild-type and floxed alleles as indicated on The Jackson Laboratory website (www.jax.org).
Immunofluorescence and In Situ Hybridization
Timed pregnancies were established between NestinCre Tg, Pitx2 þ=À males and Pitx2 flox=flox females or between Nestin-Cre Tg males and homozygous R26R females. The morning of vaginal plug identification was designated as embryonic day 0.5. Embryos (e10.5-e18.5) were harvested from the uterus after cervical Pitx2 mRNA is dispersed in Pitx2NCre mutants, and PITX2 immunofluorescence is absent. Autofluorescence from tissue folds is present in c and d. b-Galactosidase activity (X-gal staining) is distributed throughout the e18.5 midbrain, in both control (e) and Pitx2NCre mutant (f) embryos that also contain the R26R reporter. Scale bars are 100 lm. dislocation and hysterectomy, and embryos were dissected into 0.1 M PBS, pH 7.2. Yolk and amniotic sacs or caudal aspects of each embryo were processed for genotyping as described (Martin et al., 2004) . Embryos (e14.5 and e18.5) were fixed for 3 h in 4% paraformaldehyde (Sigma, St. Louis, MO), washed in PBS, and then dehydrated in an increasing series of ethanol concentrations to 100%. Dehydrated embryos were rinsed in methylsalicylate (Fisher) and embedded in paraffin wax. Embryos were sectioned at 7 lm (e10.5-e14.5) or 8 lm (e18.5). All embryos were sectioned on a microtome (Leitz) and mounted on baked super frost plus slides (Fisher, Pittsburgh, PA). Immunofluorescence and in situ hybridization were performed as described (Martin et al., 2002 (Martin et al., , 2004 ; the Pitx2 in situ probe we used recognizes Exon 5 and the 3 0 UTR, which is present in the Pitx2 somatic recombined null, germline null, floxed, and wildtype alleles (Martin et al., 2004) .
b-Galactosidase Activity Assay
Embryos (e10.5-e14.5) were harvested as described before and fixed in 0.5% formaldehyde, 1.25 mM EGTA, 2 mM MgCl 2 in PBS overnight at 48C, and then in 30% sucrose containing 2 mM MgCl 2 in PBS overnight at 48C. Embryos were embedded in Optimal Cutting Temperature embedding medium (Sakura Finetek, Torrance, CA), cryosectioned (15 lm), and stored at À808C. Sections were thawed and fixed in 0.5% glutaraldehyde (PBS, 1.25 mM EGTA, 2 mM MgCl 2 ) for 20 min, washed in buffer (sodium phosphate buffer pH 7.4 with 2 mM MgCl 2 and 0.02% NP-40 (Sigma)), and incubated for 2-24 h in X-gal wash buffer containing 1 mg X-gal (Invitrogen), 5 mM potassium ferro- , Nestin-Cre Tg) littermates. b-Galactosidase activity (X-gal staining) is present in the e18.5 subthalamic nucleus region in both control (e) and Pitx2NCre mutant (f) embryos that also contain the R26R reporter. Scale bars are 50 lm.
cyanide (Fisher), 5 mM potassium ferricyanide (Fisher), and 0.33% N-N-dimethylformamide (Sigma). Upon completion of staining, slides were transferred to wash buffer, post-fixed, and mounted.
